Tentative Program

PARALLEL SESSIONS

• Maternal mortality in the world: the real challenge
• HAPO Study-Hyperglycemia and Adverse Pregnancy Outcome–The results
• Gestational thyroid disease; when to start treatment'
• Obstetric anaesthesia and perinatal medicine: is there a missing link

• Placenta and stillbirths
• Microdeletion syndromes: An overview
• Heavy metals and neural tube defects
• Daily iatrogenic teratology: drugs, alcohol, smoking…
• Neonatal Clinical Pharmacology: the Science Investigating the Interface between Development and Pharmacogenetics

• Prevention of Preterm Delivery: Is it routinely available to everyone?
• Management of acute preterm labour
• 17 hydroxy progesterone after a successful acute tocolysis
• New markers in detection of inflammation in PPROM

• Management of IUGR: TRUFFLE results
• Hypertensive and normotensive IUGR and ultrasound Doppler
• Diagnosis and management of IUGR
• Acute problems of IUGR neonate
• Epigenetical alteration in the IUGR placenta

• Fetal reduction and late termination of pregnancy: How far should we go?
• Hot topics on multiple pregnancies
• Twin pregnancy: the choice of optimal route of delivery
• Placental examination in multiples
• Laser therapy in TTS and TRAP
• Diagnosis and therapy of TTTS
• Management of severe IUGR in one monochorionic twin

• Placental functional pathology in preeclampsia
• Placental findings in preeclamptic patients
• The pathophysiology of trophoblast invasion in causing pre-eclampsia
• Proteomics for prediction of preeclampsia
• Maternal mortality and morbidity in preeclamptic women
• Anesthesia and analgesia in preeclamptic women

• New Insights into Modern Prenatal Genetics
• Proteomics and Genomics
• Diagnosis of fetal disorders from maternal blood
• ART and PGD: Impact on the fetus and neonate
• Is there a genetic basis for preterm delivery and adverse neonatal events?

• What is routine ultrasound examination for fetal heart
• Fetal ECHO in first trimester
• Fetal ECO in second trimester
• 4D fetal echocardiography in the study of structural and functional cardiac diseases

• The Cochrane Reviews and actual Obstetric practice
• The Cochrane Reviews and actual Neonatal practice

• Prenatal and postnatal diagnostic aids: US, CT, MRI, biopsies etc.
• Fetoscopic surgery: an update
• Fetal dilemmas regarding fetal decision-making
• Prenatal Imaging (US and MRI) and cerebral development
• Postnatal Neurological Prognosis of CNS Abnormalities with Accurate Prenatal Detection
• Up-to-date Fetal Neuroimaging
• Fetal obstructive uropathy: is urine or amniotic fluid sampling useful for prenatal counselling?

• Social aspects
• What is optimal screening method for Down
• The effect of introducing first trimester combined screening
• For Downs syndrome at a national level
• NB, DV, and TR: How applicable and effective?
• An Essential Dimension of Risk Assessment and Invasive Genetic Diagnosis
• CVS and amniocentesis - what are the real risks?

• Trial of labor after caesarean section
• Caesarean section on demand & consequences
• Breech delivery and C/S

• Thromboembolic diseases in pregnancy, intra- and post partum
• Neonatal problems in antiphopholipid syndrome
• Thromboembolic problems in neonate
• Hypothyroidism in pregnancy
• Management of postpartum haemorrhage
• Surgical treatment of post-partum haemorrhage

• Neurological and cognitive development of ELBW infants
• Delivery room management and transport to NICU
• Prevention and treatment of NEC
• Soft care in NICU –How can we take care of them less invasively and less disturbing?
• EuroNeoStat: an information system to monitor outcomes in VLBW infants

• NIDCAP and End of Life Decisions
• When a newborn is bound to die -
• The Groningen protocol: how and why -
• Perinatal care in extremely preterm age -
• Dilemmas regarding decision-making in newborn at the limits of viability (22-23 weeks)
• Ethics and epidemiologic data at the threshold of viability

• Ethics in neonatal medicine
• No newborn should ever die alone
• Fetal reduction and late termination of pregnancy. How far should we go?
• End of life decision-making in newborns: How far should we go?
• Law and Perinatal ethics: Comparison between European cultures
• Equilibrium between maternal and fetal rights

• Is 3D ultrasound useful in the diagnostic of neonatal brain?
• Prevention or repair of brain damage
• IVH-PVL: are they preventable?
• Brain injury in near term infants

• Maternal infections and prematurity
• Development of innate immune system
• Diagnosis of bacterial infection in neonate
• Guidelines for selection of antibacterial therapy
• Infection control and surveillance in NICU
• Management of infant born to a mother with HIV infection.

• Pulmonary surfactant pharmacokinetics
• Surfactant therapy: prophylaxis vs. rescue
• Surfactant treatment in RDS
• Genetic disorders of surfactant structure and function
• New therapeutic applications of surfactant
• Conventional versus new ventilatory strategies in RDS patients?

• Single or repeat antenatal steroids
• Antenatal steroids after 34 wks GA
• CPAP and RDS Epicure Study
• New concepts about bronchopulmonary dysplasia
• Iatrogenic events and quality improvement programmes in neonatal care
• RDS in near term infants
• Impact of antenatal and postnatal results/interventions on respiratory outcome

• Arytmias and abnormal heart rate
• How to suspect and diagnose a cardiac baby in delivery room and NICU?
• Stabilization and invasive cardiac procedures in neonate
• Patent ductus arteriosus in preterm infant
• Blood pressure problems-Hypo-hypertension

• Early aggressive parenteral nutrition
• Early aggressive enteral nutrition
• Immunonutrition in neonate
• Postdischarge nutrition
• Promotion of breastfeeding in NICU
• Catch-up or not to catch-up?
• Early origins of adult diseases

• Metabolic screening tests-today and tomorrow
• How to suspect and diagnose a baby with metabolic disorders?
• Hearing tests
• Developmental hip dysplasia
• Different strategies in screening hypotiroidism

• Immunological/inflammatory mechanisms in neonates
• Diagnosis of bacterial infection in neonate
• Guidelines for selection of antibacterial therapy
• Infection control and surveillance in NICU

• Induction protocols and perinatal consequences
• Infertility drugs and prevalence of genetic disorders
• ART technologies and prevalence of genetic disorders
• Counselling of infertility cases for pregnancy outcome